ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,737, issued on Jan. 20.
"Systems and methods for using improved contrast agent in performing and MRI" was invented by Ronald Day (Cottonwood Heights, Utah).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of a formation agent, such as nitric oxide or sodium nitrite to produce methemoglobin as an alternative MRI contrast agent. The formation agent can be infused using either a respiratory system or a delivery mechanism. One embodiment of this invention relates to systems and methods for producing an image of an internal region with a magnetic resonance scanning system. Blood is drawn from the patient. The blood i...